Squamous cell carcinoma of the bladder: a patient treated successfully with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine. (Q53522603)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Squamous cell carcinoma of the bladder: a patient treated successfully with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

Squamous cell carcinoma of the bladder: a patient treated successfully with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

1 reference

based on heuristic

inferred from title

author name string

Kazuyoshi Shigehara

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

Yasuhide Kitagawa

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

Takao Nakashima

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

Masayoshi Shimamura

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

publication date

1 August 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

International Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

11

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

329-331

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

Pharmacodynamics of tongue tissue and plasma after intraarterial infusion of cis-diammine glycolato platinum (CDGP)

1 reference

https://api.crossref.org/works/10.1007%2FS10147-006-0571-8

21 January 2018

[Invasive squamous cell carcinoma of the bladder: report of 18 cases and review of literature]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel, ifosfamide, nedaplatin (TIN) for patients with metastatic urothelial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pure squamous cell carcinoma of the bladder in western countries. Report on 19 consecutive cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for locally advanced bladder cancer. Kyushu University Urological and Radiological Oncology Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A late phase II clinical study of cis-diammine glycolato platinum, 254-S, for head and neck cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16937309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10147-006-0571-8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16937309

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53522603&oldid=2212194723"